UPDATE: Needham & Company Upgrades Acadia Pharmaceuticals (ACAD) to Buy, $9 Price Target
Go back to UPDATE: Needham & Company Upgrades Acadia Pharmaceuticals (ACAD) to Buy, $9 Price Target| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 16.28 -0.31 (1.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.59 | 52 Week High | $42.49 | |||
| Open | $16.50 | 52 Week Low | $16.64 | |||
| Day High | $16.51 | P/E | N/A | |||
| Day Low | $16.16 | EPS | $-0.42 | |||
| Volume | 623,470 | |||||
